Overall market sentiment has been down on CEL-SCI Corporation (CVM) stock lately. CVM receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With CVM Stock Today?
CEL-SCI Corporation (CVM) stock is trading at $8.80 as of 10:22 AM on Thursday, Jul 1, an increase of $0.12, or 1.38% from the previous closing price of $8.68. The stock has traded between $8.37 and $9.40 so far today. Volume today is 2,216,733 compared to average volume of 1,963,258.
To see the top 5 stocks in the Biotechnology industry click here.
More About CEL-SCI Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Click Here to get the full Stock Score Report on CEL-SCI Corporation (CVM) Stock.
